J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
University Hospital Heidelberg, Germany
"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial
Watch Out For The Me Better 'Trap' Behind The Changing Future Of Frα Adc Rising Stars
Japanese Scientists Find That Nmn Supplementation May Treat Retinal Dysfunction Caused By Cardiovascular Disease
New Study: Nmn Supplementation Activates Longevity Proteins To Reduce Stem Cell Senescence And Restore Mitochondrial Function
